Scinai Immunotherapeutics (SCNI) Profit After Tax Growth (3y) (2017 - 2026)
Scinai Immunotherapeutics (SCNI) Profit After Tax Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 6.30% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.23% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 71.02% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 17.25% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.89% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 37.44% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -29.12% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 59.34% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -38.56% |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | 0.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.28% |
| Jun 30, 2025 | -39.86% |
| Mar 31, 2025 | 14.11% |
| Dec 31, 2024 | -28.00% |
| Sep 30, 2024 | 46.68% |
| Jun 30, 2024 | 17.89% |
| Mar 31, 2024 | 42.26% |
| Dec 31, 2023 | 36.65% |
| Sep 30, 2023 | -27.16% |
| Mar 31, 2023 | 43.44% |
| Sep 30, 2022 | 37.27% |
| Jun 30, 2022 | 30.41% |
| Mar 31, 2022 | -85.40% |
| Dec 31, 2021 | 36.64% |
| Sep 30, 2021 | -135.91% |
| Jun 30, 2021 | -20.62% |
| Mar 31, 2021 | 15.29% |
| Dec 31, 2020 | -12.09% |
| Mar 31, 2020 | -4.28% |
| Mar 31, 2019 | 47.35% |